MAZE
Maze Therapeutics Inc
NASDAQ · Pharmaceuticals
$45.03
+1.08 (+2.46%)
Performance
1D
—
1W
-3.22%
1M
+12.04%
3M
+39.58%
6M
+231.10%
1Y
+247.45%
YTD
+13.23%
Open$44.29
Previous Close$43.95
Day High$46.18
Day Low$42.79
52W High$49.25
52W Low$6.71
Volume663.5K
Avg Volume617.3K
Market Cap2.17B
P/E Ratio—
EPS$-1.20
SectorPharmaceuticals
Volume Analysis
1.07x average volume
Technical Indicators
SMA 50
$41.51
Above
SMA 200
$24.33
Above
RSI (14)
58.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+108.5% upside
Current
$45.03
$45.03
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 184.11M | 546.10M | 525.77M |
| Net Income | 20.20M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 66.92M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |